SANTA FE, N.M., June 22, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (CSE:AVBT) (Avisa), a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for ...
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. SANTA FE, N.M. and MALVERN, Pa., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Avisa Diagnostics Inc. (CSE:AVBT) (“Avisa” ...
AVISA SNAPS UP ANOTHER FROM SIGNAL: Another executive from the Signal Group has joined Avisa, the European firm growing its U.S. presence. Noe Garcia, who was previously a managing director, will be a ...
VANCOUVER, BC, and SAN CARLOS, Calif., Feb. 2, 2021 /CNW/ - FogChain Corp. (CSE: FOG.X) (OTCB: FOGCF) (FRA: MUU3) (the "Company" or "FogChain") is pleased to announce, further to its news release ...
Avisa Pharma, which is developing a breath test to detect respiratory diseases like pneumonia, COPD and tuberculosis, is raising a small debt round. The New Mexico upstart has raised $914,359 of a ...
New Delhi: Avisa Smart Hospitals has further expanded its horizons in the United Arab Emirates (UAE). Avisa Dubai started off with the appointment of Dr Abdullah Yosef, Medical Expert. The company ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results